July 06, 2026 06:44 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough
Covid-19 Vaccine
Image Credit: Firhad Hakim Twitter

Kolkata: Firhad Hakim gets vaccinated in Covaxin's phase 3 trial

| @indiablooms | Dec 02, 2020, at 11:42 pm

Kolkata/IBNS: Kolkata Municipal Corporation (KMC)'s chairman of board of administrators and West Bengal Minister, Firhad Hakim, on Wednesday got vaccinated in the third phase of trial of India's indigenous vaccine candidate against Covid-19, Covaxin.

The third phase trial was inaugurated in the city by West Bengal Governor Jagdeep Dhankhar at Kolkata's National Institute of Cholera and Enteric Disease (NICED)  on Tuesday.

After getting vaccinated, Hakim, who became the second candidate to take the dose of Covaxin in the trial, said, "I am fully fine after getting vaccinated."

"I don't care even if I die. My vaccination will be fruitful when the entire country will get vaccinated," he said.

A total of 1,000 people will participate in the third phase of the vaccine trial of Covaxin developed by Indian biotechnology company Bharat Biotech.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.